45P Alofanib in subsequent therapy of advanced gastric cancer: Final results from the phase Ib clinical trial.

MLA

Vladimirova, L. Y., et al. “45P Alofanib in Subsequent Therapy of Advanced Gastric Cancer: Final Results from the Phase Ib Clinical Trial.” Annals of Oncology, vol. 33, Mar. 2022, p. S20. EBSCOhost, https://doi.org/10.1016/j.annonc.2022.01.054.

APA

Vladimirova, L. Y., Kurakin, V., Besova, N., Statsenko, G., Mochalova, A., Trenina, N., Artamonova, E., Novoselova, K., Titova, T., Abramova, N. A., Obarevich, E., Kashanova, A., Suetina, M., Agranov, I., Iugai, S., Raskin, G., Kazey, V., Rykov, I., Tjulandin, S., & Tsimafeyeu, I. (2022). 45P Alofanib in subsequent therapy of advanced gastric cancer: Final results from the phase Ib clinical trial. Annals of Oncology, 33, S20. https://doi.org/10.1016/j.annonc.2022.01.054

Chicago

Vladimirova, L.Y., V. Kurakin, N. Besova, G. Statsenko, A. Mochalova, N. Trenina, E. Artamonova, et al. 2022. “45P Alofanib in Subsequent Therapy of Advanced Gastric Cancer: Final Results from the Phase Ib Clinical Trial.” Annals of Oncology 33 (March): S20. doi:10.1016/j.annonc.2022.01.054.